Broadpoint.Gleacher Announces Launch of Healthcare Research Vertical
2010年4月29日 - 8:30PM
ビジネスワイヤ(英語)
Broadpoint AmTech, Inc., a broker-dealer subsidiary of
Broadpoint Gleacher Securities Group, Inc. (NASDAQ: BPSG), today
announced the launch of its new Healthcare research vertical with
the hiring of Amit Hazan and Joseph France.
Mr. Hazan joins the firm from Oppenheimer and Company where
he covered medical device and diagnostics companies since 2006 in
sectors including radiation therapy, diagnostics, women’s health,
urology, orthopedics and other sub-sectors. He is widely recognized
in the industry for his proactive research, detailed survey work,
and strong relationships with investors and corporate managements
alike. Mr. Hazan has a B.A. from UCLA and earned his JD/MBA from
Santa Clara University. Also joining Mr. Hazan at Broadpoint AmTech
are Jeremy Feffer and Brandon DeLeeuw, who worked with Mr. Hazan at
Oppenheimer and are key contributors to the device team.
Mr. France joins the firm from Lenrock Management, a healthcare
fund, to cover the facilities, managed care, and services
companies. He has over twenty years of sell-side experience
covering the industry, most recently at Bank of America and Credit
Suisse. Mr. France has a wealth of industry experience and contacts
and has been recognized by Institutional Investor 13 times in his
career. He holds a B.S. in Pharmacy and an M.B.A. from the
University of Kansas. Mr. France is a Chartered Financial
Analyst.
Bob Meier, Chief Executive Officer of Broadpoint AmTech, said,
“We strongly believe that the addition of the Healthcare vertical
to our already strong Technology, Industrial, and soon to be REIT
franchises will position us very well to continue to gain share at
our key clients and drive revenue opportunities for the back half
of 2010 and beyond.”
Eric Gleacher, Chief Executive Officer of Broadpoint.Gleacher,
said, “Developing our equity platform is a critical element in our
overall growth initiative and adding highly regarded research
analysts like Amit and Joe is crucial to our success. We see
exceptional opportunities in Healthcare and we are very pleased to
welcome these accomplished individuals to our Research
Department.”
About Broadpoint.Gleacher
Broadpoint Gleacher Securities Group, Inc. (NASDAQ: BPSG) is an
independent investment bank that provides corporations and
institutional investors with strategic, research-based investment
opportunities, capital raising, and financial advisory services,
including merger and acquisition, restructuring, recapitalization
and strategic alternative analysis services. The Company offers a
diverse range of products through the Debt Capital Markets,
Investment Banking and Broadpoint DESCAP divisions of Broadpoint
Capital, Inc., its Equity Capital Markets subsidiary, Broadpoint
AmTech, and FA Technology Ventures Inc., its venture capital
subsidiary. For more information, please visit www.bpsg.com.
Forward Looking Statements
This press release contains "forward-looking statements." These
statements are not historical facts but instead represent the
Company's belief regarding future events, many of which, by their
nature, are inherently uncertain and outside of the Company's
control. The Company's forward-looking statements are subject to
various risks and uncertainties, including the conditions of the
securities markets, generally, and acceptance of the Company's
services within those markets and other risks and factors
identified from time to time in the Company's filings with the
Securities and Exchange Commission. It is possible that the
Company's actual results and financial condition may differ,
possibly materially, from the anticipated results and financial
condition indicated in its forward-looking statements. You are
cautioned not to place undue reliance on these forward-looking
statements. The Company does not undertake to update any of its
forward-looking statements.
Broadpoint Gleacher Securities Grp., Inc. (MM) (NASDAQ:BPSG)
過去 株価チャート
から 5 2024 まで 6 2024
Broadpoint Gleacher Securities Grp., Inc. (MM) (NASDAQ:BPSG)
過去 株価チャート
から 6 2023 まで 6 2024